Insmed Inc (INSM)

[coinstarz]

NETWORK OF EUROPEAN STUDIES OF GENES IN GROWTH (NESTEGG)

NESTEGG is a Pfizer sponsored study.
Pfizer has a strong interest in the field of growth. Their Endocrine Care division is committed to support the development of new diagnostic tests and treatments for children with short stature.

Pfizer have sponsored the collection of all NESTEGG families and controls and the first phase of the genetic testing. They take an active interest in the progress of the project and are represented on the Steering Committee.

About the project

NESTEGG is an International collaborative growth genomics project. The university hospitals involved are major centres with excellent track records for research in the field of childhood growth. They are now working together on NESTEGG which is the first international study of its size looking at the genetics of growth.
The aim of this study is to identify genetic influences on growth disorders before and after birth and their metabolic complications We are studying common growth problems with complex patterns of inheritance - SGA (small for gestational age birth size) and ISS (idiopathic short stature - or short stature of no defined cause). Family and case-control based approaches will be used.

http://www.brightstudy.ac.uk/cgi-bin4/home_logos.cgi?content=sponsor

About Prof. Martin Savage

Unit Head - Professor of Paediatric Endocrinology

Research Area:


Professor Martin Savage, Dr Cecilia Camacho-Hübner and Dr Linda Johnston hold academic positions in Paediatric Endocrinology. The principal interests of the unit are; the molecular and endocrine characterization of disorders of the GH-IGF-I axis, treatment of GH resistance with the recombinant IGF-I/IGFBP-3 complex, growth genetics and the investigation and treatment of paediatric Cushing’s syndrome.

http://www.whri.qmul.ac.uk/staff/Savage.html